Ballwin, MO, United States of America

Joseph J McDonald


Average Co-Inventor Count = 9.0

ph-index = 8

Forward Citations = 287(Granted Patents)

Forward Citations (Not Self Cited) = 232(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Wildwood, MO (US) (2004 - 2006)
  • Ballwin, MO (US) (1998 - 2008)

Company Filing History:


Years Active: 1998-2008

Loading Chart...
53 patents (USPTO):Explore Patents

Title: Joseph J McDonald: Pioneering Retroviral Protease Inhibitor Research

Introduction:

In the realm of medical innovation, individuals like Joseph J McDonald play a significant role in advancing life-saving treatments. Hailing from Ballwin, MO (US), McDonald is a prolific inventor who has made notable contributions in the field of retroviral protease inhibitors. With an impressive portfolio of 53 patents, including his latest breakthroughs, McDonald has solidified his position as a respected figure in the pharmaceutical industry.

Latest Patents:

One of McDonald's recent accomplishments is the development of bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors. These compounds have proven to be effective inhibitors of HIV protease, making them crucial in the fight against retroviral infections. McDonald's invention not only focuses on treatment but also on preventing the spread of retroviruses and prophylactically preventing such infections. This breakthrough has the potential to reshape the landscape of HIV treatment and prevention strategies.

Career Highlights:

McDonald's career spans across notable pharmaceutical companies, including G.D. Searle & Company and Pharmacia Corporation. At these renowned organizations, he dedicated his expertise and passion to his research on retroviral protease inhibitors. His diligent efforts have led to substantial breakthroughs and advancements in the field.

Collaborations:

Collaboration is a crucial aspect of scientific progress, and Joseph J McDonald has worked alongside notable experts in his field. Some of his esteemed coworkers include John Nicholas Freskos and Gary A DeCrescenzo. Together, they have contributed to the development and refinement of groundbreaking technologies, further solidifying their place in the annals of pharmaceutical innovation.

Conclusion:

Joseph J McDonald's dedication to advancing retroviral protease inhibitors has positioned him as an influential figure in the field. With an impressive portfolio of 53 patents, his work has the potential to revolutionize the treatment and prevention of retroviral infections. His collaboration with esteemed colleagues and contributions to companies such as G.D. Searle & Company and Pharmacia Corporation underline the importance of collective efforts in driving scientific progress. As we look to the future, we eagerly anticipate the continued contributions of inventors like Joseph J McDonald, as they shape the landscape of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…